Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
|---|---|---|---|---|---|
| BEF-M5213 | Mouse | Mouse Beta-NGF Protein, Tag Free (MALS verified) |  |
|
|
| BEF-H5214 | Human | Human Beta-NGF Protein, premium grade |  |
|
Immobilized Human Beta-NGF Protein, premium grade (Cat. No. BEF-H5214) at 1 μg/mL (100 μL/well) can bind Human TrkA (33-417), Mouse IgG2a Fc Tag (Cat. No. TRA-H5259) with a linear range of 1-16 ng/mL (QC tested).
The purity of Mouse Beta-NGF Protein, Tag Free (Cat. No. BEF-M5213) is more than 90% and the molecular weight of this protein is around 28-36 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| RGN-259 | Fx peptide; TB4 16-38; RGN-457; Thymosin beta 4-16-38; Thymosin B4; RGN-352; RGN-259; RGN-137; Tβ4; TB4; GBT-201; GBT-101; Thymosin beta4 | Phase 3 Clinical | National Institutes Of Health | Keratitis; Myocardial Ischemia; ST Elevation Myocardial Infarction; Myocardial Infarction; Graft vs Host Disease; Sjogren's Syndrome; Dry Eye Syndromes; Epidermolysis Bullosa; Pressure Ulcer; Epidermolysis Bullosa, Junctional; Varicose Ulcer; Diabetes Mellitus; Epidermolysis Bullosa Dystrophica | Details |
| Fasinumab | SAR-164877; MT-5547; R-475; REGN-475 | Phase 3 Clinical | Abdominal Pain; Sciatica; Osteoarthritis, Knee; Back Pain; Osteoarthritis; Low Back Pain; Osteoarthritis, Hip | Details | |
| MEDI-7352 | MEDI-7352 | Phase 2 Clinical | Medimmune | Chronic Pain; Diabetic Neuropathies; Osteoarthritis, Knee | Details |
| N-Hexacosanol | tCFA15; TAC-302 | Phase 2 Clinical | Meiji Seika Pharma Co Ltd | Urinary Bladder, Underactive; Urinary Bladder, Overactive | Details |
| Antibodies to humanized nerve growth factor(Shenyang Sunshine Pharmaceutical) | Phase 2 Clinical | Shenyang Sunshine Pharmaceutical Co Ltd | Bone metastases; Cancer Pain | Details | |
| EP-9001A | EP-9001A | Phase 2 Clinical | Chengdu Youluo Biotechnology Co Ltd | Bone metastases; Cancer Pain; Pain | Details |
| DS-002 | DS-002 | Phase 2 Clinical | Dartsbio Pharmaceuticals Ltd | Pain; Cancer Pain | Details |
| Atinumab | NG-101; ATI-355 | Phase 2 Clinical | Novartis Pharma Ag | Spinal Cord Injuries; Gastroparesis; Diabetic Gastroparesis | Details |
| Luvagrobart | AK-115 | Phase 1 Clinical | Zhongshan Akeso Biopharma Co Ltd | Pain; Cancer Pain | Details |
| TNM-009 | TNM-009; TNM009 | Phase 1 Clinical | Zhuhai Trinomab Pharmaceutical Co Ltd | Cancer Pain; Pain | Details |
| SMR-7694 | SMR-7694; SMR7694 | Phase 1 Clinical | Sinobioway Biomedicine Co Ltd | Osteoarthritis | Details |
| Neuroregenerative agents (iNtRON Biotechnology) | Clinical | Intron Biotechnology | Nervous System Diseases | Details | |
| RGN-259 | Fx peptide; TB4 16-38; RGN-457; Thymosin beta 4-16-38; Thymosin B4; RGN-352; RGN-259; RGN-137; Tβ4; TB4; GBT-201; GBT-101; Thymosin beta4 | Phase 3 Clinical | National Institutes Of Health | Keratitis; Myocardial Ischemia; ST Elevation Myocardial Infarction; Myocardial Infarction; Graft vs Host Disease; Sjogren's Syndrome; Dry Eye Syndromes; Epidermolysis Bullosa; Pressure Ulcer; Epidermolysis Bullosa, Junctional; Varicose Ulcer; Diabetes Mellitus; Epidermolysis Bullosa Dystrophica | Details |
| Fasinumab | SAR-164877; MT-5547; R-475; REGN-475 | Phase 3 Clinical | Abdominal Pain; Sciatica; Osteoarthritis, Knee; Back Pain; Osteoarthritis; Low Back Pain; Osteoarthritis, Hip | Details | |
| MEDI-7352 | MEDI-7352 | Phase 2 Clinical | Medimmune | Chronic Pain; Diabetic Neuropathies; Osteoarthritis, Knee | Details |
| N-Hexacosanol | tCFA15; TAC-302 | Phase 2 Clinical | Meiji Seika Pharma Co Ltd | Urinary Bladder, Underactive; Urinary Bladder, Overactive | Details |
| Antibodies to humanized nerve growth factor(Shenyang Sunshine Pharmaceutical) | Phase 2 Clinical | Shenyang Sunshine Pharmaceutical Co Ltd | Bone metastases; Cancer Pain | Details | |
| EP-9001A | EP-9001A | Phase 2 Clinical | Chengdu Youluo Biotechnology Co Ltd | Bone metastases; Cancer Pain; Pain | Details |
| DS-002 | DS-002 | Phase 2 Clinical | Dartsbio Pharmaceuticals Ltd | Pain; Cancer Pain | Details |
| Atinumab | NG-101; ATI-355 | Phase 2 Clinical | Novartis Pharma Ag | Spinal Cord Injuries; Gastroparesis; Diabetic Gastroparesis | Details |
| Luvagrobart | AK-115 | Phase 1 Clinical | Zhongshan Akeso Biopharma Co Ltd | Pain; Cancer Pain | Details |
| TNM-009 | TNM-009; TNM009 | Phase 1 Clinical | Zhuhai Trinomab Pharmaceutical Co Ltd | Cancer Pain; Pain | Details |
| SMR-7694 | SMR-7694; SMR7694 | Phase 1 Clinical | Sinobioway Biomedicine Co Ltd | Osteoarthritis | Details |
| Neuroregenerative agents (iNtRON Biotechnology) | Clinical | Intron Biotechnology | Nervous System Diseases | Details |
This web search service is supported by Google Inc.
A-Z
